Clinical Research Professional Providing Care Coordination Support: A Study of Hawaii Minority/Underserved NCORP Community Site Trial Participants.
Autor: | Izumi Okado, Pagano, Ian, Cassel, Kevin, Su'esu'e, Anamalia, Rhee, Jessica, Berenberg, Jeffrey, Holcombe, Randall F. |
---|---|
Předmět: |
MINORITIES
CLINICAL trials FOCUS groups RESEARCH methodology CROSS-sectional method AGE distribution MEDICAL care PATIENT-centered care INTERVIEWING PATIENTS' attitudes SURVEYS SEX distribution T-test (Statistics) QUESTIONNAIRES DESCRIPTIVE statistics RESEARCH funding CONTENT analysis DATA analysis software CANCER patient medical care |
Zdroj: | JCO Oncology Practice; Jul2022, Vol. 18 Issue 7, pe1114-e1121, 8p |
Abstrakt: | PURPOSE Although effective care coordination (CC) is recognized as a vital component of a patient-centered, high-quality cancer care delivery system, CC experiences of patients who enroll and receive treatment through clinical trials (CTs) are relatively unknown. Using mixed methods, we examined perceptions of CC among patients enrolled onto therapeutic CTs through the Hawaii Minority/Underserved National Cancer Institute Community Oncology Research Program. METHODS The Care Coordination Instrument, a validated instrument, was used to measure patients’ perceptions of CC among CT participants (n 5 45) and matched controls (n 5 45). Paired t-tests were used to compare overall and three CC domain scores (Communication, Navigation, and Operational) between the groups. Semistructured focus group interviews were conducted virtually with 14 CT participants in 2020/2021. RESULTS CT participants reported significantly higher total CC scores than non-CT participants (P 5 .0008). Similar trends were found for Navigation and Operational domain scores (P 5 .007 and .001, respectively). Twenty-nine percent of CT participants reported receiving high-intensity CC assistance from their clinical research professionals (CRPs). Content analysis of focus group discussions revealed that nearly half of the focus group discussions centered on CRPs (47%), including CC support provided by CRPs (26%). Other key themes included general CT experiences (22%) and CRP involvement as an additional benefit to CT participation (15%). CONCLUSION Our results show that patients on CTs in this study had a more positive CC experience. This may be attributable in part to CC support provided by CRPs. These findings highlight both the improved experience of treatment for patients participating in a trial and the generally unrecognized yet integral role of CRPs as part of a cancer CT care team. [ABSTRACT FROM AUTHOR] |
Databáze: | Complementary Index |
Externí odkaz: |